跳至主要内容
临床试验/NCT04960657
NCT04960657已完成不适用

The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers

Danish Headache Center1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2020年10月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
1
主要终点
Headache

研究概览

简要总结

To investigate the hemodynamic effects of PACAP38 after glibenclamide administration.

详细描述

22 healthy participants will randomly be allocated to receive PACAP38 infusion followed by glibenclamide or placebo on two different days.

The aim of the study is to investigate the vascular effect of PACAP38 after glibenclamide administration.

Repeated measurements covering the arteria radialis (RA), superficial temporal artery (STA) and middle cerebral artery (MCA) before and after PACAP38 infusion and glibenclamide/placebo administration

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteers of both sexes.
  • 18-60 years.
  • 50-100 kg.
  • Women of childbearing age must use adequate contraception

排除标准

  • A history of serious somatic or psychiatric disease
  • Migraine or any other type of headache (except episodic tension-type headache less than 5 days per month)
  • Daily intake of any medication except contraceptives

研究组 & 干预措施

PACAP38 and glibenclamide

Active Comparator

Participants will receive glibenclamide after PACAP38 infusion

干预措施: glibenclamide (Drug)

PACAP38 and glibenclamide

Active Comparator

Participants will receive glibenclamide after PACAP38 infusion

干预措施: PACAP38 (Drug)

PACAP38 and placebo

Active Comparator

Participants will receive placebo after PACAP38 infusion

干预措施: glibenclamide (Drug)

PACAP38 and placebo

Active Comparator

Participants will receive placebo after PACAP38 infusion

干预措施: PACAP38 (Drug)

结局指标

主要结局

Headache

时间窗: Time of headache measurements is from before (-20 minutes) and up to 12 hours after PACAP38 infusion

Headache intensity will be recorded by numerical rating scale (NRS) from 0 to 10 (0, no headache; 1, a feeling of pressure; 10, worst imaginable headache).

次要结局

  • Changes in the arterial radialis (RA), superficial temporal artery (STA) and middle cerebral artery (MCA).(Time of measurements is baseline and repeatedly every 20 minutes for 260 minutes.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lili Kokoti

MD, PhD student, Principal investigator

Danish Headache Center

研究点 (1)

Loading locations...

相似试验